Abram, M.; Jakubiec, M.; Koczurkiewicz-Adamczyk, P.; Doroz-Płonka, A.; Rapacz, A.; Kamiński, K.
Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models. Int. J. Mol. Sci. 2024, 25, 9861.
https://doi.org/10.3390/ijms25189861
AMA Style
Abram M, Jakubiec M, Koczurkiewicz-Adamczyk P, Doroz-Płonka A, Rapacz A, Kamiński K.
Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models. International Journal of Molecular Sciences. 2024; 25(18):9861.
https://doi.org/10.3390/ijms25189861
Chicago/Turabian Style
Abram, Michał, Marcin Jakubiec, Paulina Koczurkiewicz-Adamczyk, Agata Doroz-Płonka, Anna Rapacz, and Krzysztof Kamiński.
2024. "Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models" International Journal of Molecular Sciences 25, no. 18: 9861.
https://doi.org/10.3390/ijms25189861
APA Style
Abram, M., Jakubiec, M., Koczurkiewicz-Adamczyk, P., Doroz-Płonka, A., Rapacz, A., & Kamiński, K.
(2024). Development of Novel Alaninamide Derivatives with Anticonvulsant Activity and Favorable Safety Profiles in Animal Models. International Journal of Molecular Sciences, 25(18), 9861.
https://doi.org/10.3390/ijms25189861